Shiang Huang Selected Research

Shiang Huang Research Topics

Disease

23	Neoplasms (Cancer) 12/2021 - 11/2008
6	Leukemia 07/2015 - 05/2008
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 11/2008
3	Neoplasm Metastasis (Metastasis) 01/2020 - 03/2015
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2018 - 11/2005
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2012 - 07/2007
3	Stomach Neoplasms (Stomach Cancer) 06/2012 - 12/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020 - 01/2012
2	Melanoma (Melanoma, Malignant) 01/2016 - 03/2015
2	Breast Neoplasms (Breast Cancer) 01/2016 - 04/2012
1	Colorectal Neoplasms (Colorectal Cancer) 12/2021
1	Carcinoma (Carcinomatosis) 12/2021
1	Cholangiocarcinoma 01/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2020
1	Disease Progression 01/2018
1	Squamous Cell Carcinoma of Head and Neck 01/2016
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2016
1	Lewis Lung Carcinoma 03/2015
1	Glioma (Gliomas) 01/2014
1	Carcinogenesis 06/2012
1	Skin Neoplasms (Skin Cancer) 06/2012
1	Multiple Organ Failure (MODS) 12/2011
1	Gastritis 06/2011
1	Insulin Resistance 01/2006
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2006
1	Abdominal Obesity 01/2006
1	Obesity 01/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2006

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2006
5	VaccinesIBA 01/2017 - 04/2012
4	Phosphotransferases (Kinase)IBA 09/2012 - 01/2010
3	ProteomeIBA 12/2021 - 06/2012
3	Messenger RNA (mRNA)IBA 01/2019 - 05/2008
3	AntigensIBA 01/2016 - 04/2012
3	Imatinib Mesylate (Gleevec)FDA Link 09/2012 - 07/2007
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 06/2012
2	InterferonsIBA 01/2018 - 12/2011
2	LigandsIBA 09/2016 - 03/2015
2	Interleukin-10 (Interleukin 10)IBA 09/2016 - 04/2015
2	CytokinesIBA 01/2016 - 01/2016
2	ChemokinesIBA 03/2015 - 11/2008
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2012 - 04/2012
2	Ether (Diethyl Ether)IBA 08/2012 - 05/2011
2	Small Interfering RNA (siRNA)IBA 01/2012 - 12/2011
2	Insulin (Novolin)FDA Link 01/2010 - 01/2006
1	Peptides (Polypeptides)IBA 12/2021
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 12/2021
1	Rimantadine FDA LinkGeneric 01/2020
1	IntegrinsIBA 01/2020
1	CXCR ReceptorsIBA 01/2020
1	Core Binding Factors (Core-Binding Factor)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	N-cyclopropyl adenosine-5'-carboxamide (CPCA)IBA 01/2018
1	PerforinIBA 09/2016
1	plerixafor FDA Link 09/2016
1	Antitumor BIBA 09/2016
1	Interleukin-2 (IL2)IBA 09/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	A-factor (Streptomyces)IBA 07/2015
1	Fas Ligand Protein (Fas Ligand)IBA 04/2015
1	imidazole mustard (BIC)IBA 03/2015
1	CC ChemokinesIBA 03/2015
1	CCR ReceptorsIBA 03/2015
1	Conditioned Culture MediaIBA 01/2014
1	Caspase 9IBA 01/2014
1	Caspase 3 (Caspase-3)IBA 01/2014
1	SurvivinIBA 01/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2012
1	Kruppel-Like Transcription Factors (Kruppel-Like Factors)IBA 06/2012
1	Tamoxifen FDA LinkGeneric 06/2012
1	Membrane Proteins (Integral Membrane Proteins)IBA 06/2012
1	Epithelial Cell Adhesion MoleculeIBA 04/2012
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2012
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 04/2012
1	Antineoplastic Agents (Antineoplastics)IBA 01/2012
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2011
1	CreatinineIBA 12/2011
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2011
1	bcr-abl Fusion ProteinsIBA 12/2011
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2011
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 06/2011
1	Protein Kinases (Protein Kinase)IBA 06/2011
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 12/2010
1	Histones (Histone)IBA 01/2010
1	NVP ADW742IBA 01/2010
1	BerberineIBA 11/2008
1	Therapeutic UsesIBA 07/2007
1	EnzymesIBA 01/2006
1	ResistinIBA 01/2006
1	Immunoglobulins (Immunoglobulin)IBA 11/2005

Therapy/Procedure

9	Therapeutics 08/2016 - 05/2008
4	Immunotherapy 01/2020 - 04/2012
4	Drug Therapy (Chemotherapy) 07/2015 - 01/2010
1	Aftercare (After-Treatment) 01/2018
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 03/2015
1	Radiotherapy 03/2015
1	Microspheres (Microsphere) 11/2005